Literature DB >> 31425397

Implementing Data to Care-What Are the Costs for the Health Department?

Robyn Neblett Fanfair1, Ram K Shrestha1, Liisa Randall2, Crystal Lucas3, Lisa Nichols4, Nasima M Camp1, Kathleen Brady3, Heidi Jenkins5, Fredrick Altice4, Merceditas Villanueva4, Alfred DeMaria2.   

Abstract

BACKGROUND: The Cooperative Re-Engagement Controlled Trial (CoRECT) is a randomized controlled trial that uses a combined health department-provider data to care (D2C) model to identify out-of-care HIV-infected persons. We present cost data for programmatic aspects of the trial during the start-up period (first 30 days of the study).
METHODS: We used microcosting methods to estimate health department start-up costs. We collected start-up cost data between September 2016 and December 2016; 3 health departments completed a form to capture expenses for the initial 30 days of study implementation; the start date varied by health department. All costs are expressed in 2016 US dollars.
RESULTS: Among the 3 health departments, the total start-up costs ranged from $14,145 to $26,058. Total start-up labor hours ranged from 224 to 640 hours.
CONCLUSIONS: As D2C expands nationally with cooperative agreement, PS 18-1802 health departments may be able to use a similar analysis to consider the labor, time, and resources needed to implement D2C within their jurisdiction.

Entities:  

Mesh:

Year:  2019        PMID: 31425397     DOI: 10.1097/QAI.0000000000001968

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  2 in total

1.  "Is a Bird in the Hand Worth 5 in the Bush?": A Comparison of 3 Data-to-Care Referral Strategies on HIV Care Continuum Outcomes in San Francisco.

Authors:  Darpun D Sachdev; Elise Mara; Alison J Hughes; Erin Antunez; Robert Kohn; Stephanie Cohen; Susan Scheer
Journal:  Open Forum Infect Dis       Date:  2020-08-21       Impact factor: 3.835

2.  Advancing data to care strategies for persons with HIV using an innovative reconciliation process.

Authors:  Merceditas Villanueva; Janet Miceli; Suzanne Speers; Lisa Nichols; Constance Carroll; Heidi Jenkins; Frederick Altice
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.